{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:23:54Z","timestamp":1770236634085,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRM Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrc.2025.152956","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:35:56Z","timestamp":1762958156000},"page":"152956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of selective mPGES-1 inhibitors through pharmacophore modeling, molecular docking, and quantum chemical analysis"],"prefix":"10.1016","volume":"792","author":[{"given":"Venkatesan","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthukumaradoss","family":"Mohan Maruga Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-2730","authenticated-orcid":false,"given":"Kathiravan","family":"Muthukumaradoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152956_bib1","unstructured":"World Health Organization, Cancer Statist., n.d."},{"key":"10.1016\/j.bbrc.2025.152956_bib2","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.152956_bib3","article-title":"A review on mPGES-1 inhibitors: from preclinical studies to clinical applications","volume":"147","author":"Bergqvist","year":"2020","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.bbrc.2025.152956_bib4","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1038\/s41598-018-23482-4","article-title":"Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs","volume":"8","author":"Ding","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152956_bib5","first-page":"391","article-title":"Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases","volume":"13","author":"Wang","year":"2021","journal-title":"Am J Transl Res."},{"key":"10.1016\/j.bbrc.2025.152956_bib6","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1039\/C5MD00278H","article-title":"Targeting microsomal prostaglandin E 2 synthase-1 (mPGES-1): the development of inhibitors as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"6","author":"Chen","year":"2015","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bbrc.2025.152956_bib7","first-page":"1","article-title":"Selective mPGES-1 inhibitor ameliorated adjuvant-induced arthritis in the rat model","volume":"2024","author":"Kim","year":"2024","journal-title":"J. Chem."},{"key":"10.1016\/j.bbrc.2025.152956_bib8","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.3390\/molecules28166059","article-title":"mPGES-1 inhibitor discovery based on computer-aided screening: pharmacophore models, molecular docking, ADMET, and MD simulations","volume":"28","author":"Huang","year":"2023","journal-title":"Molecules."},{"key":"10.1016\/j.bbrc.2025.152956_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.152956_bib10","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1073\/pnas.1733589100","article-title":"Success of prostaglandin E 2 in structure\u2013function is a challenge for structure-based therapeutics","volume":"100","author":"Serhan","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2025.152956_bib11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152956_bib12","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1021\/jm401557w","article-title":"Aminothiazole-featured pirinixic acid derivatives as dual 5-Lipoxygenase and microsomal prostaglandin E 2 Synthase-1 inhibitors with improved potency and efficiency in vivo","volume":"56","author":"Hanke","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152956_bib13","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1073\/pnas.0802894105","article-title":"Structural basis for induced formation of the inflammatory mediator prostaglandin E 2","volume":"105","author":"Jegersch\u00f6ld","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2025.152956_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11224-022-01911-5","article-title":"In silico discovery of potential azole-containing mPGES-1 inhibitors by virtual screening, pharmacophore modeling and molecular dynamics simulations","volume":"33","author":"Ozalp","year":"2022","journal-title":"Struct. Chem."},{"key":"10.1016\/j.bbrc.2025.152956_bib15","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1039\/D3RA08618F","article-title":"Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX","volume":"14","author":"Saravanan","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.152956_bib16","doi-asserted-by":"crossref","first-page":"33770","DOI":"10.1039\/D3RA05672D","article-title":"Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach","volume":"13","author":"Chagaleti","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.152956_bib17","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"Zinc 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.152956_bib18","doi-asserted-by":"crossref","first-page":"38079","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","author":"G","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.152956_bib19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/biomedicines12040788","article-title":"Dual anti-inflammatory and anticancer activity of novel 1,5-Diaryl pyrazole derivatives: molecular modeling, synthesis, in vitro activity, and dynamics study","volume":"12","author":"Deivasigamani","year":"2024","journal-title":"Biomedicines."},{"key":"10.1016\/j.bbrc.2025.152956_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14383","article-title":"Discovery and development of <scp>COVID<\/scp> \u201019 vaccine from laboratory to clinic","volume":"103","author":"Saravanan","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2025.152956_bib21","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.55522\/jmpas.V11I5.4167","article-title":"Molecular modelling investigation on 4-aminoquinoline derivatives as potent anti-tubercular agents","volume":"11","author":"Kathiravan","year":"2022","journal-title":"Journal of Medical Pharmaceutical and Allied Sciences"},{"key":"10.1016\/j.bbrc.2025.152956_bib22","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152956_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2024.103220","article-title":"Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis","volume":"36","author":"Shanthakumar","year":"2024","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.bbrc.2025.152956_bib24","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1038\/s41598-023-30164-3","article-title":"Analgesic effects of a highly selective mPGES-1 inhibitor","volume":"13","author":"Stewart","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152956_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139116","article-title":"Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: synthesis, characterization, and computational study","volume":"1317","author":"Laamari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.152956_bib26","series-title":"Machine Learning and Systems Biology in Genomics and Health","first-page":"189","article-title":"Artificial intelligence and its application in cardiovascular disease management","author":"Namasivayam","year":"2022"},{"key":"10.1016\/j.bbrc.2025.152956_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108073","article-title":"Identification of novel CA IX inhibitor: pharmacophore modeling, docking, DFT, and dynamic simulation","volume":"110","author":"Packiapalavesam","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152956_bib28","doi-asserted-by":"crossref","first-page":"21492","DOI":"10.1039\/D3CP01490H","article-title":"Toward functionalization of ZnO nanotubes and monolayers with 5-aminolevulinic acid drugs as possible nanocarriers for drug delivery: a DFT based molecular dynamic simulation","volume":"25","author":"Mohammadzaheri","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.152956_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152956_bib30","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1039\/c3cp00116d","article-title":"Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations","volume":"15","author":"Godschalk","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.152956_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s43586-022-00184-w","article-title":"Principal component analysis","volume":"2","author":"Greenacre","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.bbrc.2025.152956_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nmeth.4346","article-title":"Principal component analysis","volume":"14","author":"Lever","year":"2017","journal-title":"Nat. Methods."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:09:32Z","timestamp":1766088572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25016729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S0006291X25016729"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152956","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of selective mPGES-1 inhibitors through pharmacophore modeling, molecular docking, and quantum chemical analysis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152956"}}